Inmobiliaria Colonial, SOCIMI, S.A.

DB:HSC2 Stock Report

Market Cap: €3.4b

Inmobiliaria Colonial SOCIMI Valuation

Is HSC2 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of HSC2 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: HSC2 (€5.36) is trading below our estimate of fair value (€5.75)

Significantly Below Fair Value: HSC2 is trading below fair value, but not by a significant amount.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for HSC2?

Key metric: As HSC2 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for HSC2. This is calculated by dividing HSC2's market cap by their current revenue.
What is HSC2's PS Ratio?
PS Ratio8.3x
Sales€413.78m
Market Cap€3.43b

Price to Sales Ratio vs Peers

How does HSC2's PS Ratio compare to its peers?

The above table shows the PS ratio for HSC2 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average7.3x
AOX alstria office REIT-AG
5.2x-1.5%€1.2b
FLY Société Foncière Lyonnaise
10.5x-5.1%€3.1b
EMBASSY Embassy Office Parks REIT
8.7x12.9%₹348.9b
CDP COPT Defense Properties
4.8x3.1%US$3.6b
HSC2 Inmobiliaria Colonial SOCIMI
8.3x3.4%€3.4b

Price-To-Sales vs Peers: HSC2 is expensive based on its Price-To-Sales Ratio (8.3x) compared to the peer average (7.3x).


Price to Sales Ratio vs Industry

How does HSC2's PS Ratio compare vs other companies in the European Office REITs Industry?

3 CompaniesPrice / SalesEstimated GrowthMarket Cap
HSC2 8.3xIndustry Avg. 8.3xNo. of Companies4PS0612182430+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: HSC2 is good value based on its Price-To-Sales Ratio (8.3x) compared to the European Office REITs industry average (8.3x).


Price to Sales Ratio vs Fair Ratio

What is HSC2's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

HSC2 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio8.3x
Fair PS Ratio18.6x

Price-To-Sales vs Fair Ratio: HSC2 is good value based on its Price-To-Sales Ratio (8.3x) compared to the estimated Fair Price-To-Sales Ratio (18.6x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst HSC2 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€5.36
€6.94
+29.6%
15.8%€8.50€4.10n/a17
Nov ’25€5.53
€6.87
+24.4%
15.9%€8.50€4.10n/a18
Oct ’25€6.19
€6.74
+8.9%
16.8%€8.50€4.10n/a19
Sep ’25€5.47
€6.54
+19.7%
17.3%€8.50€4.80n/a17
Aug ’25€5.34
€6.37
+19.4%
20.4%€8.50€3.50n/a18
Jul ’25€5.45
€6.54
+20.1%
20.1%€8.50€3.50n/a16
Jun ’25€6.19
€6.46
+4.4%
19.6%€8.50€3.50n/a16
May ’25€5.55
€6.22
+12.1%
20.1%€8.50€3.50n/a19
Apr ’25€5.39
€6.31
+17.1%
18.9%€8.50€3.50n/a19
Mar ’25€4.98
€6.37
+27.9%
18.4%€8.50€3.50n/a19
Feb ’25€5.55
€6.42
+15.8%
18.4%€8.50€3.50n/a19
Jan ’25€6.56
€6.49
-1.1%
19.3%€8.50€3.50n/a18
Dec ’24€6.01
€6.45
+7.3%
19.3%€8.50€3.50n/a19
Nov ’24€5.26
€6.64
+26.2%
19.6%€8.50€3.50€5.5317
Oct ’24€5.24
€6.84
+30.5%
18.8%€9.50€3.50€6.1917
Sep ’24€5.57
€6.87
+23.3%
18.4%€9.50€3.50€5.4717
Aug ’24€5.84
€6.88
+17.8%
18.2%€9.50€3.50€5.3417
Jul ’24€5.50
€6.95
+26.3%
18.4%€9.50€3.50€5.4516
Jun ’24€5.48
€7.01
+28.0%
17.7%€9.50€3.50€6.1916
May ’24€5.71
€7.15
+25.2%
18.7%€9.50€3.50€5.5516
Apr ’24€5.86
€7.33
+25.1%
15.3%€9.50€4.90€5.3916
Mar ’24€6.77
€7.35
+8.6%
15.3%€9.50€4.90€4.9816
Feb ’24€6.67
€7.25
+8.8%
16.0%€9.50€4.90€5.5516
Jan ’24€6.04
€7.08
+17.2%
18.1%€9.50€4.90€6.5616
Dec ’23€5.90
€7.08
+20.2%
18.0%€9.50€4.90€6.0116
Nov ’23€5.32
€7.65
+43.8%
21.4%€10.07€4.90€5.2615

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies